Chesworth Richard 4
4 · Kymera Therapeutics, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Chesworth Richard
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+60,000→ 60,000 totalExercise: $48.46Exp: 2031-02-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments over three (3) years following the Grant Date, with the first installment vesting on April 1, 2021.